UK Approves Groundbreaking Cancer Drug Toripalimab

London, Saturday, 16 November 2024.
Junshi Biosciences’ Toripalimab receives UK approval, marking a significant advancement in cancer treatment. The drug offers new hope for nasopharyngeal and esophageal cancer patients, demonstrating impressive survival benefits in clinical trials.